MEDIUM confidence: 100% data completeness, but the composite (60) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$38.1M over 180 days (0 open-market buys, 7 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.8B— | $4.0B+5.7% | $3.4B-14.1% | $3.8B+10.2% | $4.2B+10.9% |
| EPS (dil.) | $2.06— | $2.91+40.9% | $2.65-8.9% | $2.66+0.4% | $3.43+28.9% |
| Free Cash Flow | $280M— | $686M+145.2% | $619M-9.8% | $566M-8.6% | $687M+21.4% |
| Gross Margin | 22.0% | 28.1%+6.0pp | 28.9%+0.8pp | 27.7%-1.1pp | 27.4%-0.3pp |
| Operating Margin | 17.4% | 22.0%+4.6pp | 22.1%+0.1pp | 20.4%-1.7pp | 21.4%+1.0pp |
| Net Margin | 12.4% | 16.5%+4.1pp | 17.6%+1.1pp | 16.0%-1.6pp | 18.3%+2.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Buy-rated share 67% → 100% over ~3 months (+33pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.09 | $1.13 | +3.7% |
| Apr 2026 | $0.75 | $1.08 | +44.4% |
| Feb 2026 | $1.67 | $1.39 | -16.8% |
| Oct 2025 | $1.99 | $1.88 | -5.5% |
| Jul 2025 | $0.82 | $0.98 | +18.8% |
| Apr 2025 | $0.66 | $0.71 | +8.4% |
| Feb 2025 | $0.56 | $1.21 | +116.1% |
| Oct 2024 | $0.66 | $0.76 | +14.4% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.1%/yr (revenue basis).
Base free cash flow $624M (avg FY2023–FY2025; latest year $687M) · equity value $14.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 60 indicates a moderately attractive stock, driven by strong momentum and lower risk, with a score of 63 and 64, respectively. The value category scores lower at 59, due to a P/E of 17.2 and P/B of 4.1, indicating the stock trades at a premium. The long-term and short-term scores are closely aligned, suggesting a consistent outlook, with the stock exhibiting strong momentum, as evidenced by a 44.6% return over the past year and an ROE near 27%.